Gene · 3642
Papers1,406
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,406
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Early Recurrence of Non-neuroendocrine Primary Cutaneous Mucinous Carcinoma of the Eyelid After Surgical Excision: A Case Report. | Cureus | 2026 | 42802765 | PubTator, text mining | PubMed |
| Contralateral Primary Small-Cell Neuroendocrine Carcinoma of the Breast With Focal Squamous Differentiation in a Patient With Prior Invasive Ductal Carcinoma: A Rare Case. | Cureus | 2026 | 42787006 | PubTator, text mining | PubMed |
| Uterine Tumor Resembling Ovarian Sex Cord Tumor With GREB1::NCOA2 Fusion and Neuroendocrine Marker Expression: A Case Report and Literature Review. | Int J Surg Pathol | 2026 | 42770431 | PubTator, text mining | PubMed |
| Bladder Large Cell Neuroendocrine Carcinoma(LCNEC): A Case Report of Exfoliated Cytology and Pathological Characteristics. | J Vis Exp | 2026 | 42762149 | PubTator, text mining | PubMed |
| Molecular Subtyping of Biliary Tract Neuroendocrine Carcinomas: Clinicopathological Features and Prognostic Implications. | Am J Surg Pathol | 2026 | 42733321 | PubTator, text mining | PubMed |
| First Case of Mixed Poorly Differentiated Mucinous Adenocarcinoma and High-Grade Neuroendocrine Neoplasm With Amphicrine Differentiation. | Cureus | 2026 | 42732443 | PubTator, text mining | PubMed |
Neuroendocrine Differentiation in Synovial Sarcoma-An Immunohistochemical Study of 357 Tumors With 4 Markers: Chromogranin A, Synaptophysin, Insulinoma-associated Protein 1 and Insulin Gene Enhancer Protein ISL-1. | Appl Immunohistochem Mol Morphol | 2026 | 42720542 | PubTator, text mining | PubMed |
| Case Report: Hidden danger in breast eczematous lesions: cutaneous metastasis from silent lung adenocarcinoma misdiagnosed as Paget's disease. | Front Oncol | 2026 | 42688082 | PubTator, text mining | PubMed |
| TTF-1-Positive Merkel Cell Carcinoma in Situ: Extending the Neoplasm's Immunophenotypic Spectrum Through Case Study and Literature Review. | J Cutan Pathol | 2026 | 42674577 | PubTator, text mining | PubMed |
| Primary ovarian non-small cell neuroendocrine carcinoma in an adolescent: The youngest case reported to date. | Pathol Res Pract | 2026 | 42659772 | PubTator, text mining | PubMed |
| Case Report: Pancreatic amphicrine-like carcinoma with acinar differentiation harboring a KANK4-RAF1 gene fusion. | Pathol Oncol Res | 2026 | 42643275 | PubTator, text mining | PubMed |
| Solid papillary carcinoma of the breast: A clinicopathological study with emphasis on unusual immunohistochemical and genetic features. | Pathol Res Pract | 2026 | 42636673 | PubTator, text mining | PubMed |
| The Mesenteric Masquerader: A Rare Primary Neuroendocrine Tumor of the Mesentery. | Cureus | 2026 | 42633364 | PubTator, text mining | PubMed |
| INSM1 Regulates Neuroendocrine Plasticity and Tumor Progression in Prostate Cancer. | bioRxiv | 2026 | 42619793 | PubTator, text mining | PubMed |
| DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL co-culture system. | Genes Dis | 2026 | 42602894 | PubTator, text mining | PubMed |
| Pancreatic Collision Tumor Composed of Solid Pseudopapillary Neoplasm and Well-Differentiated Neuroendocrine Tumor: Diagnostic Challenges and Classification Considerations. | Cureus | 2026 | 42592296 | PubTator, text mining | PubMed |
| Primary MiNEN of the urinary bladder with large cell neuroendocrine carcinoma and enteric-type adenocarcinoma: a case report. | Front Oncol | 2026 | 42582087 | PubTator, text mining | PubMed |
| Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells. | Front Oncol | 2026 | 42568401 | PubTator, text mining | PubMed |
| Expression and prognostic significance of INSM1 compared with traditional neuroendocrine markers in mixed urothelial and small-cell carcinoma of the renal pelvis. | Front Oncol | 2026 | 42548565 | PubTator, text mining | PubMed |
| When the Skin Tells a Bigger Story: Distinguishing Cutaneous Metastases from Primary Adnexal Carcinomas in Dermatopathology. | Biology (Basel) | 2026 | 42510656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3642/papers